TACE尽管可使大部分癌细胞坏死，但不完全，癌灶周边可残留癌细胞，易复发，近10年开展的经皮经肝选择性门静脉栓塞化疗（SPVE），一般与TACE联合应用，可最大限度使肝癌灶完全缺血坏死，也可直接杀癌【121。
基于12个网页-相关网页
...肝多发转移癌的患者一期行原发肿瘤根治性切除+肝左外叶切除,术后行经皮选择性右肝门静脉栓塞化疗(portal vein chemoembolization,PVCE),二期行右半肝切除术,术后患者已无瘤生存18个月,报告如下.
基于4个网页-相关网页
【摘要】：正目的探讨不能一期手术切除的结直肠癌肝转移灶,经选择性门静脉栓塞化疗(portal vein chemo-,PVCE)后,再行肝叶切除治疗结直肠癌左右肝同时。
基于1个网页-相关网页
肝门静脉栓塞化疗 portal vein chemoembolization ; PVCE
门静脉化疗栓塞 SPVE
选择性门静脉化疗栓塞 selective portal vein chemoembolization
目的探讨肝动脉化疗栓塞加门静脉持续灌注化疗治疗原发性肝癌的临床价值。
Objective To investigate the clinical value about hepatic arterial chemoembolization and portal vein continuous perfusion chemotherapy in the treatment of primary liver cancer.
方法：49 例无手术指征肝癌患者，行单纯肝动脉栓塞与在肝动脉栓塞的基础上行肝门静脉化疗的对照研究。
Methods: 49 patients with late liver carcinoma were treated with embolism of hepatic artery and combined with chemotherapy through portal vein were reported.
放射介入栓塞化疗对肝癌合并门静脉癌栓治疗的疗效观察。
Transcatheter arterial chemoembolization therapy in the treatment of hepatocellular carcinoma with tumor thrombus of portal vein.
应用推荐